National Bank of Canada’s Bionano Genomics BNGO Stock Holding History

National Bank of Canada’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2	Hold	2	–	–	﹤0.01%	2925
2025 Q4	$3	Buy	+2	New	+$3	﹤0.01%	2861
2024 Q3	–	Hold	0	–	-$1	–	2780
2024 Q2	–	Hold	0	–	–	–	2685
2024 Q1	–	Sell	-42	Closed	-$3.13K	–	2713
2023 Q4	$4.98K	Buy	+42	New	+$4.39K	﹤0.01%	2310
2023 Q3	–	Hold	0	–	–	–	2757
2023 Q2	–	Sell	-1	Closed	-$881	–	2733
2023 Q1	$881	Hold	1	–	–	﹤0.01%	2547
2022 Q4	$1.16K	Hold	1	–	–	﹤0.01%	2571
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	2574
2022 Q2	$1K	Hold	1	–	–	﹤0.01%	2671
2022 Q1	$1K	Sell	1 -4	-80%	-$5.4K	﹤0.01%	2762
2021 Q4	$10K	Buy	+5	New	+$13.4K	﹤0.01%	2350

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

National Bank of Canada's BNGO Position: Q1 2026 in Review

National Bank of Canada held its Bionano Genomics (BNGO) position steady in Q1 2026 at 2 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #2925.

National Bank of Canada first reported a position in BNGO in Q4 2021 and has held it in 9 quarters since. The position peaked at $10K in Q4 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

National Bank of Canada held 2 shares of Bionano Genomics worth $2 as of Q1 2026.
National Bank of Canada left its Bionano Genomics share count unchanged in Q1 2026.
Bionano Genomics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2925 holding.
National Bank of Canada first reported a position in Bionano Genomics in Q4 2021 and has held it in 9 quarters since.
National Bank of Canada's Bionano Genomics position peaked at $10K in Q4 2021.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.